Cellular and molecular studies of the initial process of the photodynamic therapy in HEp-2 cells using LED light source and two different photosensitizers

Cell Biology International

Volumn 33, Issue 7, 2009, Pages 785-795

  Machado, Aline Helena Araujo ^a   Pacheco Soares, Cristina ^a   da Silva, Newton Soares ^a   Moraes, Karen C M ^a  

^a INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

Author keywords

Cell death; Gene transcription; LED; Photodynamic therapy; Phthalocyanines

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA ACTIN; CALPHOBINDIN II; CASPASE 3; CASPASE 9; CYCLOOXYGENASE 2; CYTOCHROME C; FAS ANTIGEN; PHTHALOCYANINE ZINC; PROPIDIUM IODIDE; PROSTANOID; PROTEIN BAX; PROTEIN BCL 2; TETRASULFOPHTHALOCYANINE ALUMINUM;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOLOGY; CYTOTOXICITY; FLUORESCENCE MICROSCOPY; GENETIC TRANSCRIPTION; HEP 2 CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LIGHT EMITTING DIODE; MOLECULAR BIOLOGY; PHOTODYNAMIC THERAPY;

CELL DEATH; HUMANS; INDOLES; LARYNGEAL NEOPLASMS; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 67549104863     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.04.011     Document Type: Article

References (68)

1. Almeida R.D., Manadas B.J., Carvalho A.P., and Duarte C.B. Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 1704 (2004) 59-86 10.1016/j.bbcan.2004.003
2. Anto R.J., Mukhopadhyay A., Denning K., and Aggarwal B.B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogen 23 1 (2002) 143-150
3. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., et al. Short protocols in molecular biology. 5th ed. (2002), John Wiley & Sons Inc
4. Babilas P., Travnik R., Werner A., Landthaler M., and Szeimies R.M. Split-face study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Ges 6 1 (2008) 25-33 10.1111/j.1610-0387.2007.06555
5. Bhattacharjee M., Acharya S., Ghosh A., Sarkar P., Chatterjee S., Kumar P., et al. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation. Int Immunol 20 12 (2008) 1489-1505 10.1093/intinmm/dxn109
6. Biel M.A. Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 83 5 (2007) 1063-1068 10.1111/j.1751-1097.20007.00153
7. Bossy-Wetzel E., and Green D.R. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274 (1999) 17484-17490
8. Buytaert E., Matroule J.Y., Durinck S., Close P., Kocanova S., Vandenheede J.R., et al. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 27 (2008) 1916-1929 10.1038/sj.onc1210825
9. Cao Y., and Prescott S.M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190 (2002) 279-286 10.1002/jcp.10068
10. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiag Photodyn Ther 2 1 (2005) 1-23 10.1016/S1572-1000(05)00030-X
11. Castano A.P., Mroz P., and Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6 (2006) 535-545 10.1038/nrc1894
12. Cauchon N., Tian H., Langlois R., La-Madeleine C., Martin S., Ali H., et al. Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines. Bioconjug Chem 16 (2005) 80-89 10.1021/bc049848t
13. Collier A.C., and Pritsos C.A. The mitochondrial uncoupler dicumarol disrupts the MTT assay. Biochem Pharmacol 66 2 (2003) 281-287 10.1016/S0006-2952(03)00240-5
14. Cuzzocrea S., and Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int 71 (2007) 290-297 10.1038/sj.ki.5002058
15. 4 and photodynamic therapy. Vet Parasitol 146 (2007) 175-181 10.1016/j.vetpar.2007.02.006
16. Dubuc C., Langlois R., Bénard F., Cauchon N., Klarskov K., Tonec P., et al. Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate. Bioorg Med Chem Lett 18 7 (2008) 2424-2427 10.1016/j.bmcl.2008.02.051
17. Duijnhoven F.H., Rovers J.P., Engelmann K., Krajina Z., Purkiss S.F., Zoetmulder F.A.N., et al. Photodynamic therapy with 5,10,15,20-tetrakis(m-hydroxyphenyl) bacteriochlorin for colorectal liver metastases is safe and feasible: results from a phase I study. Ann Surg Oncol 12 10 (2005) 808-816 10.1245/ASO.2005.09.005
18. 4. Lasers Med Sci 18 (2004) 207-212 10.1007/s10103-003-0282-6
19. Galluzzi L., Maiuri M.C., Vitale I., Zischka H., Castedo M., Zitvogel L., et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 14 (2007) 1237-1266 10.1038/sj.cdd.4402148
20. Goldberg Z., Rocke D.M., Schwietert C., Berglund S.R., Santana A., Jones A., et al. Human in vivo dose-response to control low-dose low linear energy transfer ionizing radiation exposure. Clin Cancer Res 12 12 (2006) 3723-3729 10.1158/1078-0432.CCR-05-2625
21. Goldestein P., and Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 32 (2007) 37-43 10.1016/j.tibs.2006.11.001
22. Gomer C.J. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy (yearly review). Photochem Photobiol 54 (1991) 1093-1107 10.1111/j.1751-1097.1991.tb02133.x
23. Gomer C.J., Luna M., Ferrario A., and Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic therapy or photofrin incubation. Photochem Photobiol 53 (1991) 275-279 10.1111/j.1751-1097.1991.tb03934
24. Gottlieb R.A. Role of mitochondria in apoptosis. Crit Rev Eukaryot Gene Expr 10 (2000) 231-239 10.1046/j.1432-1327.1999.00717
25. Green D.R. Apoptotic pathways: ten minutes to dead. Cell 121 (2005) 671-674 10.1016/j.cell.2005.05.019
26. Gross A., McDonnell J.M., and Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13 (1999) 1899-1911
27. Henderson B.W., and Donovan J.M. Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res 49 (1989) 6896-6900
28. ® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 194 3 (2003) 363-375 10.1002/jcp.10273
29. Huang H.F., Chen Y.Z., and Wu Y. ZnPcS2P2-based photodynamic therapy induces mitochondria-dependent apoptosis in K562 cells. Acta Biochim Biophys Sin 37 7 (2005) 488-494 10.1111/j.1745-7270.2005.00067
30. Hubmer A., Hermann A., Uberriegler K., and Krammer B. Role of calcium in photodynamically induced cell damage of human fibroblasts. Photochem Photobiol 64 (1996) 211-215 10.1111/j.1751-1097.1996.tb02444
31. 2+ influx induced by photodynamic action in human cerebral glioma (U-87 MG) cells: possible involvement of a calcium channel. Photochem Photobiol 60 (1994) 244-248 10.1111/j.1751-1097.1994.tb05098
32. Kriska T., Korytowski W., and Girotti A.W. Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Arch Biochem Biophys 433 2 (2005) 435-446 10.1016/j.abb.2004.09.025
33. Kroemer G., Galluzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16 1 (2009) 3-11 10.1038/cdd.2008.150
34. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., and Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated proteinkinase p38 signaling cascade. Mol Cell Biol 20 (2000) 4265-4274
35. Lasa M., Brook M., Saklatvala J., and Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 21 (2001) 771-780 10.1128/MCB.21.3771-780.2001
36. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv Cancer Res 74 (1998) 49-139
37. Li W.-T., Tsao H.-W., Chen Y.-Y., Cheng S.-W., and Hsu Y.-C. A study on the photodynamic properties of chlorophyll derivates using human hepatocellular carcinoma cells. Photochem Photobiol Sci 6 (2007) 1341-1348 10.1039/b704539e
38. Lobner D. Comparison of the LDH, MTT assays for quantifying cell death: validity for neuronal apoptosis?. J Neurosci Methods 96 2 (2000) 147-152 10.1016/S0165-0270(99)00193-4
39. Machado A.H.A., Braga F.M.P., Pacheco-Soares C., Pelisson M.M.M., Beltrame Jr. M., and Da-Silva N.S. Photodynamic therapy with a new photosensitizing agent. Photomed Laser Surg 25 3 (2007) 220-228 10.1089/pho.2006.2035
40. Machado A.H.A., Pacheco-Soares C., Beltrame Jr. M., Pacheco M.T.T., and Da-Silva N.S. Cytotoxicity of octal-bromide zinc phthalocyanine after photodynamic therapy with different light sources. Photomed Laser Surg 26 5 (2008) 455-459 10.1089/pho.2007.2117
41. Maftoum-Costa M., Naves K.T., Oliveira A.L., Tedesco A.C., Da-Silva N.S., and Pacheco-Soares C. Mitochondria, endoplasmic reticulum and actin filament behavior after PDT with chloroaluminum phthalocyanine liposomal in HeLa cells. Cell Biol Int 32 8 (2008) 1024-1028 10.1016/j.cellbi.2008.04.005
42. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., Van Schie R.C., LaFace D.M., et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182 5 (1995) 1545-1556
43. Miller J.D., Baron E.D., Sculla H., Hsia A., Berlin J.C., McCormick T., et al. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 224 3 (2007) 290-299 10.1016/j.taap.2007.01.025
44. Mollace V., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57 (2005) 217-252 10.1124/pr.57.2.1
45. Moor A.C.E. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 57 1 (2000) 1-13 10.1016/S1011-1344(00)00065-8
46. Morris R.L., Azizuddin K., Lam M., Berlin J., Nieminen A.L., Kenney M.E., et al. Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy. Cancer Res 63 (2003) 5194-5197
47. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63 10.1016/0022-1759(83)90303-4
48. Nomura K., Imai H., Koumura T., Kobayashi T., and Nakagawa Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem J 351 Pt 1 (2000) 183-193
49. Nunes S.M.T., Sguilla F.S., and Tedesco A.C. Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives. Braz J Med Biol Res 37 (2004) 273-284 10.1590/S0100-879X2004000200016
50. Oleinick N.L., Morris R.L., and Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1 (2002) 1-21 10.1039/b108586q
51. Pazos M.C., Ricci R., Simioni A.R., Lopes C.C., Tedesco A.C., and Nader H.B. Putative role of heparan sulfate proteoglycan expression and shedding on the proliferation and survival of cells after photodynamic therapy. Int J Biochem Cell Biol 39 6 (2007) 1130-1141 10.1016/j.biocel.2007.02.008
52. Penning L.C., Rasch M.H., Ben-Hur E., Dubbelman T.M.A.R., Havelaar A.C., Van der Zee J., et al. A role for the transient increase of cytoplasmic free calcium in cell rescue after photodynamic treatment. Biochim Biophys Acta 1107 (1992) 255-260 10.1016/0005-2736(92)90412-F
53. Penning L.C., Keirse M.J.N.C., VanSteveninck J., and Dubbelman T.M.A.R. Calcium mediated PGE2 induction reduces hematoporphyrin derivative induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro. Biochem J 292 (1993) 237-240
54. 4. Photomed Laser Surg 25 3 (2007) 175-179 10.1089/pho.2007.2040
55. 4-photosensitized rat bladder RR 1022 epithelial cells. Photochem Photobiol 72 (2000) 210-216 10.1562/0031-8655
56. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
57. Shen X.Y., Zacal N., Singh G., and Rainbow A.J. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol 81 2 (2007) 306-313 10.1111/j.1751-1097.2005.tb00188
58. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 (2000) 145-182 10.1146/annurev.biochem.69.1.145
59. Subbaramaiah K., Marmo T.P., Dixon D.A., and Dannenberg A.J. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2 and Hur. J Biol Chem 278 (2003) 37637-37647 10.1074/jbc.M301481200
60. Tapajós E.C.C., Longo J.P., Simioni A.R., Laçava Z.G.M., Santos M.F.M.A., Morais P.C., et al. In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. Oral Oncol 44 11 (2008) 1073-1079 10.1016/j.oraloncology.2008.01.013
61. Trevisi L., Pighin I., Bazzan S., and Luciani S. Inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) endocytosis by ouabain in human endothelial cells. FEBS Lett 580 11 (2006) 2769-2773 10.1016/j.febslet.2006.04.040
62. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440-442 10.1038/335440a0
63. Vellonen K.S., Honkakoski P., and Urtti A. Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci 23 2 (2004) 181-188 10.1016/j.ejps.2004.07.006
64. Wei Q., Dong G., Franklin J., and Dong Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 72 (2007) 53-62 10.1038/sj.ki.5002256
65. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7916
66. Yslas E.I., Durantini E.N., and Rivarola V.A. Zinc-(II) 2,9,16,23-tetrakis (methoxy) phthalocyanine: potential photosensitizer for use in photodynamic therapy in vitro. Bioorg Med Chem 15 (2007) 4651-4660 10.1016/j.bmc.2007.03.079
67. Zhu T.C., and Finlay J.C. The role of photodynamic therapy (PDT) physics. Med Phys 35 7 (2008) 3127-3136 doi: 10.1118/1.2937440
68. Zhuang S., and Kochevar I.E. Ultraviolet A radiation induces rapid apoptosis of human leukemia cells by Fas ligand-independent activation of the Fas death pathways. Photochem Photobiol 78 (2003) 61-67 10.1562/0031-8655